You CAN manage the challenging & complex risk management issues facing healthcare today!

  • Decrease font size
  • Default font           size
  • Increase font size
10/22/2009: Action needed to improve Medical Product Investigators processes PDF Print E-mail
Written by Joshua I Rozovsky   
Thursday, 22 October 2009 18:48

The GAO released a report released September 25, recommending that oversight of clinical investigators be improvement. The report, entitled "Oversight of Clinical Investigators:  Action Needed to Improve Timeliness and Enhance Scope of FDA's Debarment and Disqualification Processes for Medical Product Investigators" is numbered  GAO-09-807 and is accessible as a PDF file here.

Last Updated on Friday, 23 October 2009 18:49
 

News from the Web

[1/1] CDC Emergency Preparedness and Response: What's New
An RSS feed of new postings to the EPR site.

[1/3] UPDATED: Gulf Oil Spill 2010 Health Surveillance

[2/3] NEW: CDC Response to the Gulf of Mexico Oil Spill

[3/3] UPDATED: Gulf Oil Spill 2010 Health Surveillance
[1/1] SANS Institute Security Awareness Tip of the Day


[1/3] Revoking security access isn't always enough

[2/3] Secure your Wireless Router

[3/3] Choose a password that's hard to crack
[1/1] CDC's Public Health Law News
Weekly digest of happenings around the world pertaining to law and the public's health.

[1/3] Announcement: Disease, Disaster, Bioterrorism Report

[2/3] Announcement: 2008 National Obesity Summit

[3/3] Announcement: Isolation and Quarantine Training
[1/1] GAO Saved Search : "National Institutes of Health" +"risk management"


[1/2] Herbal Dietary Supplements: Examples of Deceptive or Questionable Marketing Practices and Potentially Dangerous Advice, May 26, 2010

[2/2] National Institutes of Health: Completion of Comprehensive Risk Management Program Essential to Effective Oversight, September 11, 2009
[1/1] AHA What's New
What's New on aha.org.

[1/4] Advisory : Hospital Compare: New Hospital-Acquired Conditions Data

[2/4] Letter : AHA Comments to the FCC Re: Rural Health Care Support Mechanism

[3/4] Letter : AHA Letter to DOJ and HHS re enforcement initiatives under the auspices of the False Claims Act

[4/4] Letter : AHA Comments to CMS Re: OPPS, ASC, GME, costs and Physician Self-Referral Proposed Rule for 2011